| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Carvedilol versus propranolol effect on hepatic venous pressure gradient at 1 month in patients with index variceal bleed: RCT
|
Gupta, Vipin
|
|
2016
|
11 |
2 |
p. 181-187
|
article
|
| 2 |
Clinical validity of Metroticket calculator in transplant patients undergoing prior chemoembolization for hepatocellular carcinoma
|
Kim, Hyung-Don
|
|
2017
|
11 |
2 |
p. 209-219
|
article
|
| 3 |
Efficacy and safety of daclatasvir plus pegylated-interferon alfa 2a and ribavirin in previously untreated HCV subjects coinfected with HIV and HCV genotype-1: a Phase III, open-label study
|
Sulkowski, Mark S.
|
|
2017
|
11 |
2 |
p. 188-198
|
article
|
| 4 |
Elbasvir/grazoprevir for treatment of chronic hepatitis C virus infection
|
Papudesu, Chandana
|
|
2016
|
11 |
2 |
p. 152-160
|
article
|
| 5 |
Existence of cancer stem cells in hepatocellular carcinoma: myth or reality?
|
Machida, Keigo
|
|
2016
|
11 |
2 |
p. 143-147
|
article
|
| 6 |
HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma
|
Lin, Shi-Ming
|
|
2016
|
11 |
2 |
p. 199-208
|
article
|
| 7 |
Living donor liver transplant (LDLT) is the way forward in Asia
|
Rela, Mohamed
|
|
2017
|
11 |
2 |
p. 148-151
|
article
|
| 8 |
Secondary prophylaxis for variceal bleeding: carvedilol vs. propranolol
|
Steib, Christian J.
|
|
2017
|
11 |
2 |
p. 141-142
|
article
|
| 9 |
Sofosbuvir/velpatasvir: a pangenotypic drug to simplify HCV therapy
|
Lee, Rebecca
|
|
2016
|
11 |
2 |
p. 161-170
|
article
|
| 10 |
Sofosbuvir/velpatasvir: a pangenotypic drug to simplify HCV therapy
|
Lee, Rebecca
|
|
|
11 |
2 |
p. 161-170
|
article
|
| 11 |
Virus-induced hepatocellular carcinoma with special emphasis on HBV
|
Wang, Ming
|
|
2017
|
11 |
2 |
p. 171-180
|
article
|
Journal description